100
Participants
Start Date
January 1, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Dratumumab / Hyaluronidase Injection [Darzalex Faspro]
Daratumumab will be administered at the FDA-approved dose of 16mg/kg as an intravenous infusion.
Pomalidomide 4 MG
Patients received oral pomalidomide on days 1-21 of a 28-days cycle from cycle 1 to 6.
autologous stem cell transplantation (ASCT)
"The ASCT protocol included mobilisation with colony-stimulating factor alone and conditioning with high-dose melphalan140-200 mg/m2~."
RECRUITING
National Clinical Research Center for Kidney Diseases, Jinling Hospital, Nanjing
Nanjing University School of Medicine
OTHER